140 related articles for article (PubMed ID: 37099729)
1. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
Atia O; Friss C; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Matz E; Dotan I; Turner D
J Crohns Colitis; 2023 Nov; 17(10):1614-1623. PubMed ID: 37099729
[TBL] [Abstract][Full Text] [Related]
2. Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.
Atia O; Friss C; Focht G; Magen Rimon R; Ledderman N; Greenfeld S; Ben-Tov A; Loewenberg Weisband Y; Matz E; Gorelik Y; Chowers Y; Dotan I; Turner D
J Crohns Colitis; 2024 Jan; 18(1):38-46. PubMed ID: 37465992
[TBL] [Abstract][Full Text] [Related]
3. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
Savelkoul EHJ; Maas MHJ; Bourgonje AR; Crouwel F; Biemans VBC; den Broeder N; Russel MGVM; Römkens TEH; de Boer NK; Dijkstra G; Hoentjen F
J Crohns Colitis; 2022 Sep; 16(9):1372-1379. PubMed ID: 35303065
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
[TBL] [Abstract][Full Text] [Related]
5. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
Vasudevan A; Raghunath A; Anthony S; Scanlon C; Sparrow MP; Gibson PR; van Langenberg DR
Dig Dis Sci; 2019 Jun; 64(6):1622-1631. PubMed ID: 30560332
[TBL] [Abstract][Full Text] [Related]
6. Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
Atia O; Orlanski-Meyer E; Lujan R; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Gabay H; Matz E; Nevo D; Israeli E; Schwartz D; Chowers Y; Dotan I; Turner D
J Crohns Colitis; 2022 Jun; 16(5):778-785. PubMed ID: 34791083
[TBL] [Abstract][Full Text] [Related]
7. Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long-term nationwide study from the epi-IIRN.
Plotkin L; Buchuk R; Lujan R; Focht G; Greenfeld S; Kariv R; Weisband YL; Lederman N; Matz E; Dotan I; Reifen R; Turner D
Aliment Pharmacol Ther; 2024 Jul; 60(2):224-232. PubMed ID: 38742605
[TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study.
Atia O; Goren I; Fischler TS; Weisband YL; Greenfeld S; Kariv R; Ledderman N; Matz E; Rimon RM; Dotan I; Turner D; Yanai H
Aliment Pharmacol Ther; 2023 May; 57(9):1004-1013. PubMed ID: 36894866
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries.
Kante B; Vuyyuru SK; Kedia S; Sahu P; Kumar P; Ranjan MK; Virmani S; Sharma R; Madhusudhan KS; Panwar R; Das P; Makharia G; Ahuja V
Indian J Gastroenterol; 2022 Aug; 41(4):343-351. PubMed ID: 35997952
[TBL] [Abstract][Full Text] [Related]
10. Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
Atia O; Friss C; Focht G; Magen Rimon R; Ledderman N; Ben-Tov A; Loewenberg Weisband Y; Matz E; Gorelik Y; Chowers Y; Dotan I; Turner D
Inflamm Bowel Dis; 2024 Jan; ():. PubMed ID: 38190498
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
Turner D; Doveh E; Cohen A; Wilson ML; Grossman AB; Rosh JR; Lu Y; Bousvaros A; Deslandres C; Noble A; Baldassano RN; Levine A; Lerner A; Wilson DC; Griffiths AM
Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM
Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
Mesonero F; Castro-Poceiro J; Benítez JM; Camps B; Iborra M; López-García A; Torres P; Esteve M; Tosca J; Bertoletti F; Almela P; Calvet X; Vera I; Bujanda L; Gomollón F; Rodríguez C; Antolín B; Busquets D; Hernández A; Rivero M; Monfort I Miquel D; Castaño-García A; Gisbert JP; Domènech E; López-Sanromán A;
Aliment Pharmacol Ther; 2021 May; 53(9):1021-1029. PubMed ID: 33715177
[TBL] [Abstract][Full Text] [Related]
16. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study.
Jun YK; Ji E; Yang HR; Choi Y; Shin CM; Park YS; Kim N; Lee DH; Yoon H
Therap Adv Gastroenterol; 2024; 17():17562848241248321. PubMed ID: 38741927
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
Suárez Ferrer C; González-Lama Y; González-Partida I; Calvo Moya M; Vera Mendoza I; Matallana Royo V; Arevalo Serrano J; Abreu Garcia L
Dig Dis Sci; 2019 Mar; 64(3):875-879. PubMed ID: 30542812
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.
Fukuchi T; Nakase H; Ubukata S; Matsuura M; Yoshino T; Toyonaga T; Shimazu K; Koga H; Yamashita H; Ito D; Ashida K
BMC Gastroenterol; 2014 Jul; 13():124. PubMed ID: 25015328
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
